IL1B and diabetes mellitus: Subsequently, MIN6 cells were treated with a cytokine mixture of TNF-α, IL-1β and IFN-γ in the presence or absence of UC, and verapamil, a TXNIP inhibitor for prevention of beta cell loss and diabetes development [25], was used as a positive control in this study.